Furthermore, mutation analysis results indicate that RARA-AS1 has the highest mutation frequency in esophagogastric cancer, breast cancer, and adrenocortical carcinoma, with amplification as the main mutation form in the first two types of cancer and deep deletion as the main form in the latter (Supplementary Fig. 1). Here, RARA is linked to breast cancer.